A novel class of bis-indole compounds capable of enhancing the cyto-differentiating effect of retinoids in acute promyelocytic leukemia cells.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F01%3A00000614" target="_blank" >RIV/62157124:16370/01:00000614 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
A novel class of bis-indole compounds capable of enhancing the cyto-differentiating effect of retinoids in acute promyelocytic leukemia cells.
Original language description
All-trans retinoic acid (ATRA) is the only example of clinically useful cyto-differentiating agent, causing complete remission in acute promyelocytic leukemia (APL) patients. However, the clinical use of ATRA is limited by a number of problems, which include a narrow spectrum of activity , systemic and local toxicity, as well as induced resistance. Using the APL-derived and ATRA-sensitive NB4 cell line, we identified a novel class of retinoid sensitizers characterized by a bis-indole chemical structure.The prototypic molecule is ST1346. When NB4 cells are challenged with ST1346 (1-10 micromolar) alone for three days, no significant growth inhibition or cyto-differentiation is observed. By contrast, the induction of several granulocytic maturation markers triggered by ATRA is enhanced by the combination of ST1346+ATRA. The bis-indole shifts the cyto-differentiating activity of ATRA to lower concentrations without affecting the anti-proliferative activity of the retinoid. These potentia
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2001
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Supplement to Clinical Cancer Research
ISSN
1078-0432
e-ISSN
—
Volume of the periodical
7
Issue of the periodical within the volume
11
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
1
Pages from-to
3653-3852
UT code for WoS article
—
EID of the result in the Scopus database
—